Trial Profile
Modulation of Sorafenib Induced Autophagy Using Hydroxychloroquine in Hepatocellular Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Jul 2023
Price :
$35
*
At a glance
- Drugs Hydroxychloroquine (Primary) ; Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 28 Jun 2023 Planned End Date changed from 1 Mar 2024 to 1 Mar 2025.
- 28 Jun 2023 Planned primary completion date changed from 1 Mar 2023 to 1 Mar 2024.
- 16 Sep 2022 Planned End Date changed from 1 Apr 2023 to 1 Mar 2024.